The genetics of pancreatic cancer
- 1 September 2003
- journal article
- review article
- Published by Elsevier BV in The American Journal of Surgery
- Vol. 186 (3), 279-286
- https://doi.org/10.1016/s0002-9610(03)00226-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivoGene Therapy, 2001
- K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16INK4A, p21WAF-1, cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinomaInternational Journal of Cancer, 2000
- Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4MutationsNew England Journal of Medicine, 1995
- Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaNature Genetics, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988